dc.contributor.author |
Daniel Moreno, Alberto |
|
dc.contributor.author |
Raju, Janani |
|
dc.contributor.author |
Schlegel, Patrick |
|
dc.contributor.author |
Seitz, Christian |
|
dc.contributor.author |
Atar, Daniel |
|
dc.contributor.author |
Selvaraj, Justin Antony |
|
dc.contributor.author |
Handgretinger, Rupert |
|
dc.contributor.author |
Mezger, Markus |
|
dc.contributor.author |
Ureña Bailén, Guillermo |
|
dc.contributor.author |
Lamsfus Calle, Andrés |
|
dc.date.accessioned |
2021-06-22T08:57:57Z |
|
dc.date.available |
2021-06-22T08:57:57Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
2041-2657 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/116399 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Oxford Univ Press |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1093/bfgp/elz039 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210304112512_01852 |
|
utue.publikation.seiten |
191-200 |
de_DE |
utue.personen.roh |
Urena-Bailen, Guillermo |
|
utue.personen.roh |
Lamsfus-Calle, Andres |
|
utue.personen.roh |
Daniel-Moreno, Alberto |
|
utue.personen.roh |
Raju, Janani |
|
utue.personen.roh |
Schlegel, Patrick |
|
utue.personen.roh |
Seitz, Christian |
|
utue.personen.roh |
Atar, Daniel |
|
utue.personen.roh |
Antony, Justin S. |
|
utue.personen.roh |
Handgretinger, Rupert |
|
utue.personen.roh |
Mezger, Markus |
|
dcterms.isPartOf.ZSTitelID |
Briefings in Functional Genomics |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
19 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |